Annual CFI
$2500.00
+$2.31 M+100.11%
01 December 2023
Summary:
Altamira Therapeutics annual cash flow from investing activities is currently $2500.00, with the most recent change of +$2.31 million (+100.11%) on 01 December 2023. During the last 3 years, it has risen by +$2.65 million (+100.09%). CYTO annual CFI is now at all-time high.CYTO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
01 June 2024
Summary:
Altamira Therapeutics quarterly cash flow from investing activities is not available.CYTO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
01 June 2024
Summary:
Altamira Therapeutics TTM cash flow from investing activities is not available.CYTO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +100.1% | - | - |
| 5 y5 years | +100.1% | - | - |
CYTO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +100.1% | ||||
| 5 y | 5 years | at high | +100.1% | ||||
| alltime | all time | at high | +100.1% |
Altamira Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $2500.00(-100.1%) | - | - |
| Dec 2022 | -$2.31 M(-39.8%) | - | - |
| Dec 2021 | -$3.83 M(+44.7%) | - | - |
| Dec 2020 | -$2.65 M(-14.4%) | - | - |
| Dec 2019 | -$3.10 M(+67.3%) | - | - |
| Dec 2018 | -$1.85 M(+1715.3%) | -$1.90 M(-2851.1%) | -$1.85 M(-4426.2%) |
| Sept 2018 | - | $69.10 K(-450.8%) | $42.80 K(-147.3%) |
| June 2018 | - | -$19.70 K(<-9900.0%) | -$90.50 K(+56.8%) |
| Mar 2018 | - | $0.00(-100.0%) | -$57.70 K(-43.4%) |
| Dec 2017 | -$102.00 K(-41.2%) | -$6600.00(-89.7%) | -$102.00 K(-66.3%) |
| Sept 2017 | - | -$64.20 K(-590.1%) | -$302.90 K(+37.9%) |
| June 2017 | - | $13.10 K(-129.6%) | -$219.70 K(-4.1%) |
| Mar 2017 | - | -$44.30 K(-78.7%) | -$229.10 K(+32.0%) |
| Dec 2016 | -$173.50 K | -$207.50 K(-1192.1%) | -$173.50 K(-455.5%) |
| Sept 2016 | - | $19.00 K(+413.5%) | $48.80 K(+174.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | $3700.00(-67.3%) | $17.80 K(-147.2%) |
| Mar 2016 | - | $11.30 K(-23.6%) | -$37.70 K(-13.9%) |
| Dec 2015 | -$43.90 K(-96.3%) | $14.80 K(-223.3%) | -$43.80 K(-96.3%) |
| Sept 2015 | - | -$12.00 K(-76.8%) | -$1.19 M(+0.7%) |
| June 2015 | - | -$51.80 K(-1096.2%) | -$1.18 M(-956.2%) |
| Mar 2015 | - | $5200.00(-100.5%) | $137.80 K(-111.5%) |
| Dec 2014 | -$1.20 M(+2952.9%) | -$1.13 M(>+9900.0%) | -$1.20 M(+1745.8%) |
| Sept 2014 | - | -$3700.00(-100.3%) | -$65.00 K(-25.1%) |
| June 2014 | - | $1.27 M(-195.0%) | -$86.80 K(-93.6%) |
| Mar 2014 | - | -$1.33 M(<-9900.0%) | -$1.36 M(+3350.8%) |
| Dec 2013 | -$39.30 K(-32.4%) | $5300.00(-120.8%) | -$39.40 K(-11.9%) |
| Sept 2013 | - | -$25.50 K(+264.3%) | -$44.70 K(+132.8%) |
| June 2013 | - | -$7000.00(-42.6%) | -$19.20 K(+57.4%) |
| Mar 2013 | - | -$12.20 K | -$12.20 K |
| Dec 2012 | -$58.10 K | - | - |
FAQ
- What is Altamira Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Altamira Therapeutics?
- What is the all time high quarterly CFI for Altamira Therapeutics?
- What is the all time high TTM CFI for Altamira Therapeutics?
What is Altamira Therapeutics annual cash flow from investing activities?
The current annual CFI of CYTO is $2500.00
What is the all time high annual CFI for Altamira Therapeutics?
Altamira Therapeutics all-time high annual cash flow from investing activities is $2500.00
What is the all time high quarterly CFI for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly cash flow from investing activities is $1.27 M
What is the all time high TTM CFI for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM cash flow from investing activities is $137.80 K